CASE DISCUSSION

Ulcerative colitis: Diagnosis & Management

Presented from India by Dr. Gopi Srikanth

Likes

3055

Views

122

Bookmarks

Case Description

Ulcerative colitis is diagnosed through a combination of clinical evaluation, laboratory tests, imaging studies, and endoscopic examination of the colon. Key diagnostic tests include stool studies to rule out infections, blood tests for inflammatory markers like C-reactive protein and fecal...

Case Summary

Inflammatory bowel diseases (IBD) are autoimmune disorders affecting the gut, primarily categorized into ulcerative colitis (UC), Crohn's disease, and indeterminate colitis. The pathophysiology involves genetic predisposition, environmental factors, and altered gut microbiota, leading to immune dysregulation and intestinal ulceration. Westernized diets, rich in processed foods, saturated fats, and sugars, increase IBD risk.

Speaker Profile

Dr. Gopi Srikanth

Consultant Gastroenterologist, Yashoda Hospitals, Hyderabad

Dr. Gopi Srikanth, MD (PGIMER), DM & Fellowship (AIIMS, New Delhi), EUS Fellowship (WISE, WEO), is a distinguished gastroenterologist with extensive expertise in digestive and liver diseases, advanced endoscopy, and obesity management. His clinical knowledge and expertise are further strengthened by his distinguished career as a faculty at AIIMS, New Delhi, the most prestigious medical institution in India. He has published several research papers in top medical journals and attended many national conferences as faculty. Currently practicing at Yashoda Hospitals, Hitec City, Dr. Gopi is recognized for his exceptional skills in diagnosing and treating complex gastrointestinal disorders. He is known for his compassionate and patient-centred approach to care and his ability to convey complex medical information in a clear and understandable manner.

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.